Colorcon Adds Lab in Beijing
Colorcon expands its presence in China with a technical service center to serve the northern region.
Colorcon has announced that the company opened a new technical service laboratory in Beijing, China on June 25. Located in the Beijing YiZhuang Biomedical Park, the technical center is the company’s second facility in China and 19th worldwide.
Equipped for research-scale solid dose development, the laboratory support the development and commercialization pharmaceutical drug formulations from initial product concept, to pilot scale trials through to final production and registration.
The company established Shanghai Colorcon Coating Technology Limited in 1993 and made additional strategic investments in China in a supply chain and the local manufacture of Opadry film coatings.
Source: Colorcon
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
